Partial cytogenetic response with toceranib and prednisone treatment in a young dog with chronic monocytic leukemia

Summary

Treatment of chronic monocytic leukemia (CMoL) in dogs has traditionally consisted of hydroxyurea. The use of tyrosine kinase inhibitors has been proposed as a treatment option for dogs with CMoL but has never been reported. We report a case of CMoL in a young dog that achieved clinical remission with treatment with the tyrosine kinase inhibitor toceranib and prednisone.

Read on publishers site

Fitzpatrick Referrals
Twitter
Email
Facebook
Print
AddThis